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A major role of CD62P/CD15s interaction in leukocyte margination
during hemodialysis. We investigated expression of several antigens on
neutrophils and monocytes, involved in cell adhesion, from patients
hemodialyzed with cellulosic and polyacrylonitrile membranes. Among
the antigens tested only the expression of CD15s and CD11b was
significantly increased on neutrophils and monocytes in patients dialyzed
with cellulosic membranes. No changes occurred with polyacrylonitrile
membranes. Leukocyte counts from patients dialyzed with cuprophane
membranes decreased at the same time as expression of cellular CD15s
increased, resulting in a significant negative correlation at all time points
tested. No correlation was found between the drop of monocytes and their
expression of CD11b. When CD15s expression increased on neutrophils
and monocytes, we observed a concomitant increase of CD62P, a specific
selectin of activated platelets. When whole blood cells were incubated with
complement activated serum both antigens increased but not when cells
were incubated with hrC5a. We also observed that CD61, a platelet
phenotypic antigen, was present on leukocytes incubated with complement
activated serum. At the time when platelet-leukocyte coaggregates de-
creased, CD62P expression remained stable on leukocytes, suggesting that
both neutrophils and monocytes are able to trap either CD62P shed by
activated platelets or soluble CD62P present in normal human serum. The
present study documents a major role of P-selectin (CD62P)/sialyl-Lewis
x (CD15s) interaction in the transient leukocyte margination during
hemodialysis.
The contact of blood with artificial membranes may activate cell
adhesion processes and initiate the leukocyte inflammatory re-
sponse which itself plays an important role in the pathophysiolog-
ical changes occurring during hemodialysis [1—3]. Cellular adhe-
sion is a critical phenomenon which guides cell margination and
their subsequent transendothelial migration [4, 5]. Adhesion
molecules are also implied in cell-cell interactions leading to
cellular activation and production of mediators of the inflamma-
tory response [6—8]. Several studies have shown that neutropenia
and monocytopenia take place during hemodialysis procedure
using cellulosic membranes [9, 10]. The leukocyte margination has
been associated with complement activation which occurs during
hemodialysis on cuprophane membranes [1, 11, 12] and to the
increased expression of Mol/Mac-1 antigen (CR3 receptors,
CD1 lb/CD18 heterodimer) on leukocytes [13, 14]. Recently sev-
eral adhesion molecules belonging to the selectin, integrin, immu-
noglobulin, and as yet unidentified families have been implicated
in tethering, activation, strong adhesion and motility of leukocytes
on the endothelium [51. During hemodialysis it is proposed that
the transient margination of leukocytes mainly involves tethering
phenomena implicating interactions of selectin with their natural
ligands. L-selectin, E-selectin and P-selectin have been character-
ized and shown to mediate a degree of adhesion that allows rolling
(tethering) of the leukocyte but not firm adhesion, explaining the
transient nature of cellular binding through selectin interactions
[16]. The transient nature of this adhesive interaction is strength-
ened by the fact that selectins are shed by activated cells [17]. The
purpose of our study was to investigate the mechanisms underly-
ing leukocyte margination and activation during hemodialysis.
Therefore, we have studied the expression of adhesion molecules
on leukocytes obtained from patients dialyzed with cuprophane,
cellulose acetate and polyacrylonitrile (AN69) membranes by
cytofluorometric analysis.
Methods
Patient population
Eighteen end-stage renal disease patients who were between 25
and 77 years old (mean SD, 49 21) from the E. Rist
Hemodialysis Center, 6 end-stage renal disease patients who were
between 26 and 68 years old (mean SD, 42 18) from the
Nephrology Department, Hôpital Broussais, and 4 end-stage
renal disease patients who were between 74 and 78 years old
(mean SD, 76 2) from the AURA Hemodialysis Center, were
hemodialyzed for more than six months.
Positive history for first use syndrome, clinical evidence of
infection at the time of the study, cardiac and vascular instability,
unstabilized erythropoetin dosage and single needle dialysis were
exclusion criteria. None of the patients received any medications
known to affect leukocyte or platelet function for at least two
weeks prior the study. Informed consent was obtained from all
subjects.
Study design
Ten patients were dialyzed using cuprophane membranes
(GFE15 Gambro, Sweden; Sorin 1508, France); 12 patients were
dialyzed using polyacrylonitrile membranes (AN69, Hospal,
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France) and 6 patients were dialyzed using acetate cellulose
membranes (CA15O, Baxter, USA). Recruitment of patients was
without bias concerning the type of membrane. A bicarbonate
base dialysate was used in all cases. Blood flow rates were between
250 and 300 mi/mm; dialysate flow rate was 500 ml/min. Ultrafil-
tration rates were between 500 and 1000 mi/hour. Anticoagulation
was maintained using heparin as an initial bolus and then by
continuous infusion during the course of dialysis. Venous blood
from hemodialysed individuals was collected in K3 EDTA vacu-
tainers. In a first set of experiments blood samples from 20
patients were drawn pre-dialysis (T:0) from the afferent line and
then subsequently from the efferent line at 15 minutes (T:15) and
at the end of the dialysis session (T:240). In a second set of
experiments blood samples were drawn from 8 patients pre-
dialysis (T:0) from the afferent line and then subsequentely from
the efferent line at 5 (T:5), 10 (T:10), and 15 (T:15) minutes, and
at the end of the dialysis session (T:240). Samples were kept cold
before use.
Blood samples were also collected from seven healthy individ-
uals for in vitro experiments.
Reagents and buffers
Phosphate buffered saline (PBS) was from bioMérieux (Marcy
l'Etoile, France). Serum albumin bovine (BSA) and sodium azide
(NaN3) were from Sigma Chemical Co. (St. Louis, MO, USA).
Sephadex® G25 was from Pharmacia Fine Chemicals (Uppsala,
Sweden). Suspension of particles was prepared as previouly
reported [18]. Mouse monoclonal antibodies (mAb) anti-CD15s,
anti-CD14, anti-CD15, anti-CD11a, anti-CD11b, anti-CD11c, an-
ti-CD18, anti-CD49d, anti-CD54, anti-CD61, anti-CD62P and
anti-CD62L, FITC-conjugated anti-CD15, PE-conjugated anti-
CD14 and isotypic Ab controls were purchased from Becton
Dickinson (Mountain View, CA, USA) and Immunotech (Mar-
seille, France). FITC-conjugated anti-mouse IgF(ab')2 fragment
was from Silenus Laboratories (Australia).
Flow cytometric analysis
Neutrophils and monocytes. Whole blood (300 j.tl) was incubated
with decomplemented human AB serum (1.5 ml) for 10 minutes
at room temperature in order to decrease nonspecific binding, and
centrifuged at 4°C. The pellet was incubated with 1 ig of first
mAb diluted in PBS-BSA 1%-sodium azide 0.1% (staining me-
dium) or 10 l of conjugated mAb for 30 minutes at 4°C. Samples
were washed twice in PBS-BSA 1%. If an unlabeled first step
antibody was to be used, samples were incubated with a second
affinity isolated FITC-conjugated anti-mouse Ig F(ab')2 fragment
(50 l of 1/100 dilution) for 30 minutes at 4°C. Cells were washed
once in staining medium. Erythrocytes were lysed by adding 2 ml
of lysing solution (FACS lysing solution, Becton Dickinson) for
five minutes at room temperature. This last procedure was
repeated until complete lysis of red blood cells occurred. Samples
were washed twice with the staining medium and cells were fixed
by adding 0.3 ml of cold paraformaldehyde (1%) and stored in the
dark at 4°C until analysis. Stained cells were characterized by flow
cytometric analysis (FACScan cytometer Becton Dickinson). The
instrument was set to measure linear forward light scatter (FSC),
which is a measure of cell size, linear side light scatter (SSC),
which is a measure of granularity, 538 nM fluorescein fluorescence
(FL1), 507 flM phycoerythrin fluorescence (FL2). Fluorescence
parameters were collected using four decade logarithmic amplifi-
cation. Neutrophils and monocytes were identified in the linear
forward versus linear side scatter plot by use of subgroup specific
anti-mAbs: CD15 and CD14 for neutrophils and monocytes,
respectively. Mouse isotypic antibodies were used as negative
controls.
Platelets. CD62P is a specific marker of activated platelets [19]
whereas CD61 is a marker of resting and activated platelets [20].
A total of 100 p1 EDTA anticoagulated whole blood was incu-
bated for two hours at 4°C with 1 ml of 1% cold paraformalde-
hyde. The fixed cells were centrifugated at 1200 Xg for five
minutes at room temperature; the pellets were washed twice in 1
ml of PBS with 0.1% azide. Fifty microliters of fixed blood
suspension were incubated with 20 p1 of mAb. After 20 minutes
incubation at room temperature samples were washed once in 1
ml of PBS 0.1% azide. Samples were then incubated with the
second anti-mouse FITC-IgF(ab')2 fragments (50 1.d of 1/100
dilution) in the dark, at room temperature, for 20 minutes.
Samples were washed once in 1 ml of PBS 0.1% azide. Platelets
were fixed by adding 1 ml of cold 1% paraformaldehyde and
stored in the dark at 4°C. FACScan analysis was performed within
three days. The FACScan instrument was set to measure logarith-
mic FSC, logarithmic SSC and 611 nM fluorescein fluorescence
(FL1). Fluorescence parameters were collected using four decade
logarithmic amplification. Platelets were identified in the logarith-
mic FSC versus logarithmic SSC plot by use anti-mAb CD61: the
gated platelet population was found to bind > 90% the anti-
CD61. Mouse IgGl was used as a negative control.
Platelet-leukocyte interaction. mAb-anti CD62P was used to
evaluate platelet-leukocyte interaction during hemodialysis with
cuprophane and polyaciylonitrile membranes. The mean intensity
of fluorescence of anti-CD62P on neutrophils and monocytes was
used to characterize platelet leukocyte interaction. Neutrophil
and monocyte surface staining with mAb anti-CD62P, and their
FACS analysis were performed as described above.
Six thousand events were collected in list mode files for
neutrophils, monocytes and platelets and were analyzed on
Hewlett Packard computer equipped with FACScan software
program (LYSIS II version 1.1).
In vitro stimulation of whole blood cells by Sephadex or rC5a.
Human blood (N = 4) was collected from healthy individuals in
dry vacutainers and in K3 EDTA vacutainers. Serum was obtained
after centrifugation and then incubated with 150 mg/ml of crushed
Sephadex for one hour at 37°C before adding a solution of EDTA
5 mM [18]. Complement activation was evaluated by quantification
of C3a/C3adesArg. Whole blood cells from the donors were
obtained after discarding only the plasma by centrifugation. The
plasma was replaced by the same amount of complement acti-
vated autologous serum, and the cells incubated for 5, 10, 15 and
45 minutes at 37°C. Whole blood cells from healthy donors (N =
3) were also stimulated with recombinant C5a (rC5a). Whole
blood samples were incubated with rC5a (250ng/ml) for 30
minutes at 37°C. Leukocyte samples were then kept cold. Cell
surface staining with mAbs anti-CD15s, anti-CDI ib, anti-CD62P
and anti-CD61, and their FACScan analysis were performed as
described above.
Analytical methods
Blood cell counts were performed using the Coulter STKS
System (Coultronics, USA); C3a/C3adesArg was done using a
radioimmunoassay (Amersham, France).
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Table 1. Expression of surface molecules involved in cell adhesion on neutrophils and monocytes obtained from hemodialyzed patients
Neutrophils Monocytes
T:0 T:15 T:240 T:0 T:15 T:240
Antigens MEl (%) MFI (%) MFI (%) MFI (%) MFI (%) MFI (%)
CD 15s 281 74 (96) 469 109 (96) 219 79 (98) 117 38 (80) 285 101 (91) 105 40 (94) 1
272 75 (99) 592 226 (100) 308 52 (10) 153 46 (87) 463 249 (97) 153 28 (86) 2
328 109 (100) 357 85 (100) 303 82 (98) 166 43 (87) 176 73 (85) 168 60 (83) 3
CD ha 33 8(98) 30 6(97) 30 11(98) 83 19(95) 75 20(94) 80 18(91) 1
37±3(97) 38±4(98) 37±4(95) 77±7(97) 71±6(94) 79±10(91) 237 3(96) 37 3(96) 35 2(94) 84 14(98) 81 8(97) 77 7(95) 3
CD11b 53±20(99) 71±23(99) 44±17(99) 54±26(97) 58±26(93) 51±22(91) 1
49± 14(97) 63± 19(99) 56± 17(98) 46±8(80) 56± 16(90) 61 11(88) 2
55± 17(88) 54±8(96) 50± 13(93) 58±5(96) 52±7(93) 57± 13(92) 3CD lie 16 4 (52) 16 4(36) 16 4(50) 27 7(86) 20 5 (65) 28 9(90) 126 7 (34) 28 8 (58) 29 7 (31) 41 7 (59) 38 4 (62) 45 5 (74) 2
27 5(38) 26±4(36) 26 5(38) 43 8(80) 42 6(69) 41 6(77) 3
CD 18 84 31(97) 90 31(99) 88 36(96) 122 16(91) 149 38 (90) 126 49(88) 1
82 17 (100) 96 19 (100) 81 16 (100) 127 23 (94) 118 18 (97) 126 14 (99) 2
83 20(99) 88 10(100) 78 20(100) 145 31(99) 138 18(99) 137 32(97) 3
CD 49d 24 3 (6) 25 6 (4) 21 6 (3) 26 6 (77) 29 14 (69) 25 6 (71) 1
32±6(10) 33±12(17) 34±5(9) 38±5(60) 36±5(65) 38±5(60) 2
26±12(7) 25±11(6) 24±11(6) 39±4(60) 39±2(66) 38±5(58) 3CD 54 17 7 (6) 21 10 (7) 18 6 (5) 29 8 (80) 37 30 (75) 27 6 (74) 1
26 8 (9) 27 10(11) 27 4 (6) 34 6 (40) 32 5 (40) 33 5 (51) 2
29 3 (4) 28 3 (6) 26 4 (3) 35 7 (56) 35 7 (53) 33 6 (45) 3
CD62L 69±22(97) 80± 15(97) 68±23(97) 68± 12(86) 87± 11(90) 66±20(82) 1
89± 19(99) 92± 18(98) 86±7(99) 88± 12(75) 95 16(90) 79± 15(92) 2
86 13(98) 88 12(98) 90 13(99) 88 12(83) 95 16(84) 79 15(80) 3
Patients were dialyzed with cuprophane (N = 6) (1), cellulose acetate (N = 6) (2) and polyacrylonitrile (AN69) (N = 8) (3) membranes. Cells were
collected before dialysis (T:0), 15 minutes after (T:15) and at the end of dialysis session (T:240). Results are expressed as mean fluorescence intensity
(MFI) SEM; numbers in parentheses are percentage of positive cells.
Statistics
For CD15s, CD11b, CD61 molecules, results were expressed as
mean SEM of fluorescence intensity. For CD62P the marker
expressed after platelet activation, results are represented as the
percentage of positive cells SEM for platelets and means SEM
of fluorescence intensity for neutrophils and monocytes. Statisti-
cal analysis was performed using the Student's paired t-test. P
values < 0.05 were considered to be statistically significant.
Results
Expression of adhesive molecules on leukocytes from
hemodialyzed patients
We have previously reported that cytokines are produced
during hemodialysis in patients dialysed with cuprophane mem-
branes and 24 hours after dialysis in patients dialyzed with
synthetic high permeability membranes [12, 21]. Since cytokines,
such as IL-i and TNFa, regulate the expression of adhesive
molecules responsible for neutrophils and monocyte margination
and extravasation [22, 23], we have investigated the expression of
adhesive molecules on both cell types. Expression of integrins
CD11a/CD18(LFA-1), CD11b/CD18(CR3), CD11c/CD18(CR4),
CD49d/CD29(VLA-4), the selectin CDo2L, and antigens related
to adhesive phenomena CD1Ss (sialyl-Lewis x) and CD54
(ICAM-1) was studied. Blood from patients dialyzed with cu-
prophane, cellulose acetate and polyacrilonitrile (AN69) mem-
branes, known for their varying capacity to activate the comple-
ment system, were collected at different time points before the
dialysis session (T:0), 15 minutes after starting the hemodialysis
procedure (T:15) and at the end of the session (T:240). Expres-
sion of these molecules was investigated by indirect cytofluoro-
metric analysis using specific fluorescent monoclonal antibodies as
described in the Methods section. The results indicate that among
the different antigens tested, only the expression of CD15s and
CDI lb increased significantly on neutrophils after 15 minutes of
hemodialysis with cuprophane membranes as compared with
predialysis values (469 109 vs. 281 74, P < 0.007 for CD15s
antigen; 71 23 vs. 53 20, P < 0.05 for CD11b antigen; Table
1). On monocytes only CD15s expression was up-regulated (285
101 at T:15 vs. 117 38 at TO, P < 0.005). Expression of CD49d,
CD11a, CD11c and CD54, on both type of cells, was not affected
by the dialysis procedure. Similar results were observed with the
cells obtained from the patients dialyzed with cellulose acetate
(Table 1). Hemodialysis with polyacrylonitrile dialyzers did not
affect the expression of CD15s and CD11b on both neutrophils
and monocytes.
Leukocyte counts
Figure 1 depicts the changes in neutrophil and monocyte counts
that occurred during hemodialysis using cuprophane and poly-
acrilonitrile membranes. The number of monocytes and neutro-
phils dropped dramatically at 15 minutes. Monocyte numbers
returned to predialytic levels, but the number of neutrophils was
significantly higher at the end of dialysis session than as predialysis
values (P < 0.05). No significant changes occurred when patients
were dialyzed with polyacrylonitrile membranes (AN69).
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Fig. 1. Time course of neutrophil (A) and
monocyte (B) counts during dialysis with
cuprophane ) and polyactylonitrile membranes
(LII). Neutrophil and monocyte counts were
determined for four patients dialyzed with
cuprophane membranes and four patients
dialyzed with polyacrylonitrile (AN69) at
various time points of the dialysis session.
Results are expressed as means SEM,
compared to pre-dialysis values (T:0) by
Student's t-test for paired data: * < 0.005,
** P < 0.05, ° P < 0.005, °°P < 0.05.
Fig. 2. Modulation of neutrophil and monocyte
CDJ5s and CD]Ib expression during dialysis with
cuprophane () and polyactylonitrile (ANO9)
membranes (LII). Expression of CD15s and
CD11b was analyzed on neutrophils and
monocytes obtained from the same patients at
the same time points as those depicted in
Figure 1. Results presented in A are expressed
as mean fluorescence intensity SEM of surface
CD15s and CD11b on neutrophils (*P < 0.002,
**p < 0.02, °P < 0.005, °°P < 0.008, °°°P <
0.02 compared to pre-dialysis values (TO) by
Student's t-test for paired data); expression of
the same surface antigens on monocytes is
represented in B (*P < 0.04, °P < 0.05,
compared to pre-dialysis values (T:O) by
Student's t-test for paired data).
Expression of CDI5s and CD1Ib on leukocytes during on monocytes obtained from the same patients (Fig. 2B). CD15s
hemodialysis with cuprophane and polyaciylonitrile membranes antigen expression did not change when patients were dialyzed
with polyacrylonitrile membranes (AN69) (Fig. 2 A, B). Expres-
Expression of CDI5s and CD11b was investigated on neutro- sion of CD1Ib on neutrophils from patients dialyzed with cu-
phils and monocytes at the same time points depicted in Figure 1. prophane membranes increased significantly at five minutes to
Expression of CD15s on neutrophils increased significantly during reach maximal values at 15 minutes (87 30 T:O vs. 156 43, P
hemodialysis with cuprophane membranes to reach maximal <0.02; 87 30 T:0 vs. 252 49 T:15, P < 0.005). At the end of
values at 15 minutes (1441 319 T:15 vs. 529 190 T:0; P < the dialysis session, expression of CD11b did not reach predialysis
0.002) and decreased to values below those obtained prior to values (185 24 T:240 vs. 87 30 T:0, P < 0.008). CD11b
dialysis at the end of the session (325 110 T:240 vs. 529 190 expression was only slightly affected on monocytes during the
T:O, P < 0.02; Fig. 2A). Expression of CD15s increased similarly dialysis procedure. No changes in CD11b expression occurred
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when monocytes were obtained from patients dialyzed with
polyacrylonitrile membranes (AN69).
Figure 3 depicts negative correlation between CD15s expres-
sion and neutrophil or monocyte numbers, indicating that CD15s
is directly involved in the margination of circulating neutrophils
and monocytes during hemodialysis using cuprophane devices.
Activation of platelets during hemodialysis session
We followed the expression of CD62P on platelets obtained
from patients dialyzed with cuprophane and polyacrylonitrile
membranes at the different time points during the hemodialysis
session mentioned above. The results presented in Figure 4
indicate that platelets are highly activated at five minutes of
dialysis on cuprophane and that the expression of CD62P de-
creases slowly at 10 minutes to reach minimal values at the end of
Fig. 3. Correlation curves between neutrophils
counts (x axis) and mean fluorescence intensily of
CD15s and CDJJb (y axis) on neutrophils (A, B)
and monocytes (C, D) during cuprophane dialysis
session. A significantly negative correlation was
found between the expression of CD11b
molecules (P < 0.03) and neutrophil counts, as
well as between CD15s molecules and cell
counts, but to a higher magnitude (P < 4e7).
A significantly negative correlation was also
found between CD15s (P < 6e4) and
monocyte counts during dialysis.
Fig. 4. Total (A) and activated (B) platelet
counts during dialysis with cuprophane (U) and
polyaciylonitrile (AN69) membranes (E).
Activation of platelets was assessed by their
binding to anti-CD62P. *p < 0.005, **p <
0.009, ** *p < 0.03 compared to pre-dialysis
values (T:0) by Student's t-test for paired data.
dialysis. No significant changes were observed on platelets ob-
tained from patients dialyzed with polyacrylonitrile (AN69) (Fig.
4).
Binding of platelets to leukocytes during hemodialysis
Since CD62P (P-selectin) molecules expressed on activated
platelets constitue one of the ligands of CD15s expressed on both
neutrophils and monocytes [19, 24, 25], we decided to investigate
the binding of activated platelets on both types of cells. The
results depicted in Figure 5 indicate that activated platelets bind
to neutrophils and monocytes within five minutes of the dialysis
session on cuprophane membranes. The relative numbers of
CD62P positive neutrophils reached maximal values of positive
CD62P cells (T:5, 73 3 CD62P) within five minutes and
decreased at the end of the dialysis session (T:240, 59 3%
CD15s CDllb
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Fig. 5. Effect of dialysis with cuprophane (U)
and polyactylonitrile (AN69) membranes (E) on
platelet-neutrophil and platelet-monocyte
aggregation. Activated platelets induced by
cuprophane dialysis bound significantly to
neutrophils (A) and monocytes (B) during the
dialysis session: *p < 55p < 0.003, 0 p <
0.04 compared to pre-dialysis values (T:0) by
Student's t-test for paired data. Insert represent
percentage of monocytes expressing CD62P
during cuprophane (squares) and
polyacrylonitrile (AN69) (circles) hemodialysis.
CD62P). One hundred percent of the circulating monocytes in
patients dialyzed with cuprophane membranes expressed low
levels of CD62P (T:0, MFI 48 10). CD62P expression
increased during dialysis to reach maximal values at 15 minutes
(T:15, MFI = 210 84). The expression of CD62P antigen on
both neutrophils and monocytes did not return to predialysis
values. No changes occurred with cells from patients dialyzed with
polyacrylonitrile (AN69) membranes.
In vitro studies
To further investigate the mechanisms implicated in the in-
crease in the expression of CD15s and CD11b on circulating
leukocytes and the induction of platelet-leukocyte aggregate
formation, autologous activated human serum was added to whole
blood from four healthy individuals. Normal human serum was
activated by Sephadex, which has a closely related structure to
cuprophane, and C3a/C3adesArg formation was assessed by RIA
(Sephadex activated normal human serum = 72 140 nglml;
unactivated normal human serum = 325 nglml). Figures 6, 7 and
8 show the modulation of the expression of CD15s, CD11b,
CD62P and CD61 on neutrophils and monocytes. At the same
time points expression of CD15s on neutrophils increased signif-
icantly at 5 minutes to reach maximal values at 10 minutes of
incubation (666 164 T:0 vs. 792 180 T:5, P < 0.03; 666 164
T:0 vs. 829 175 T:10, P < 0.02). Expression of CD15s increased
similarly and more significantly on monocytes (201 10 T:0 vs.
321 29 T:5, P < 0.003; 201 10 T:0 vs. 353 27 T:10, P <
0.002). The expression of CD1 lb antigen on both neutrophils and
monocytes significantly increased at 5 minutes to reach maximal
values at 15 minutes of incubation (neutrophils: 100 25 T:0 vs.
201 26 T:5, P < 0.001; 100 25 T:0 vs. 284 64 T:15, P < 0.03;
monocytes: 109 37 T:0 vs. 190 24 T:5, P < 0.02; 109 37 T:0
vs. 230 24 T:15, P < 0.02). Despite the increased expression of
CD15s and CD1 lb on neutrophils and monocytes incubated with
complement-activated autologous serum, whole blood cells incu-
bated in the presence of recombinant hC5a did not exhibit an
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Fig. 6. Stimulation of whole blood from healthy
individuals with autologous normal human semm
activated with Sephadex. Expression of CD15s
and CD11b antigens on neutrophils, obtained
from four healthy individuals, at different time
points of incubation (A, B) and evaluation of
platelet-neutrophil aggregates as assessed by
CD61 and CD62P expression on the neutrophils
(C,D).
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Fig. 8. Flow cytometty analysis of CD6J expression on neutrophils (A) and monocytes (B) stimulated in vitro by autologous serum activated by SephadeL
The results are those from one representative experiment Out of four. The clear profiles show negative controls and darkened profile show CD61
expression on cells cultured for 0, 5, 10, 15 and 45 minutes in the presence of activated serum.
altered expression of CD15s on both cell types; expression of
CD11b was only increased on monocytes (Table 2.). Figure 8
showed the kinetics of CD6I expression on neutrophils and
monocytes as assessed by flow cytometry. The results are those
from one representative experiment out of four. No significant
change in surface antigen expression on leukocytes occurred in
To evaluate the formation of platelet-leukocytes aggregates at
different time points during incubation of whole blood with
autologous activated human serum, we examined the appearance
of CD61 and CD62P on the surface of neutrophils and monocytes.
CD62P is expressed on activated platelets, CD61 is expressed on
resting and activated platelets. The results depicted in Figure 6
the presence of autologous serum that has not been incubated indicate that maximal values of positive CD61 neutrophils oc-
with Sephadex (data not shown). curred at 10 minutes of incubation (T:10 78 2 CD61 +). The
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Fig. 7. Stimulation of whole blood from healthy
individuals with autologous normal human serum
activated with Sephadex. Expression of CDI5s
and CD11b antigens on monocytes obtained
from the same donors as those depicted in
Figure 6, at different time points of incubation
(upper panels) and evaluation of platelet-
monocytes aggregates as assessed by CD61 and
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Table 2. Expression of CD15s and CD11b (MFI) on neutrophils and
monocytes cultured in the presence of recombinant C5a
Neutrophils Monocytes
4°C 37°C C5a (37°C) 4°C 37°C C5a (37°C)
CD15s 888 1081 1070 362 441 430
CD11b 102 146 143 102 107 123
The results are of a representative experiment out of three.
relative numbers of positive CD62 neutrophils reached maximal
values at five minutes of incubation (T:5 80 8 CD62+). In
Figure 7 the mean fluorescence intensity of a 100% pure positive
CD61 monocytes reached maximal values at 10 minutes of
incubation (T:10 MFI = 390 37). At 45 minutes of incubation
the anti-CD62P binding to 100% of monocytes reached the
maximal values (T:45 MFI = 210 66).
Discussion
Hemodialysis on cellulosic membranes is associated with tran-
sient leukocyte margination [1, 9—lfl. Leukocyte margination is
dependent on the expression of selectins and integrins which is
modulated by several mediators of the inflammatory response [5].
The present study demonstrates that dialysis with cellulosic mem-
branes is associated with an increase of CD15s, CD11b, CD62P
and CD62L expression on neutrophils and monocytes. Expression
of CD11a, CD11c, CD18, CD49d and CD54 was not affected by
the dialysis procedure. No changes in selectin or integrin expres-
sion occurred on leukocytes obtained from patients dialyzed with
polyacrylonitrile (AN69) membranes. Our results also indicate
that hemodialysis with cuprophane induces platelet activation
followed by their aggregation on both neutrophils and monocytes.
The selectins initiate many critical interactions among blood
cells [261. Evidence that they play a crucial role in leukocyte
trafficking has emerged in the last past few years [15, 16, 27].
Recently ligands for the selectins have been characterized [28]
and among them, the sialyl-Lewis x molecules, also termed
CD15s. CD15s has been shown to bind to E-selectin expressed on
cytokine activated endothelial cells [25, 29], P-selectin expressed
on rapidly activated endothelial cells and on platelets activated by
thrombin, histamine or PAF [19, 30, 31], and L-selectins consti-
tutively expressed on neutrophils, monocytes and lymphocyte
subsets [4]. In human a genetic disorder called leukocyte adhesion
deficiency type II, has been shown to be associated with CDI5s
deficiency and abnormal leukocyte trafficking [32]. In the present
study, we investigated the expression of CD 15s on neutrophils and
monocytes from patients undergoing hemodialysis in order to gain
some insight into the hemodialysis induced margination of leuko-
cytes. Our results clearly indicate that CD15s is up-regulated on
neutrophils and m000cytes obtained at 15 minutes of hemodial-
ysis with cuprophane membranes. At the end of hemodialysis,
expression of CD15s was lower than that observed in samples
collected prior to the dialysis session. Cells obtained from patients
dialyzed with cellulose acetate membranes also expressed higher
amounts of CD15s. No significant changes occurred with cells
obtained from patients dialyzed with polyacrylonitrile (AN69)
membranes. Similar results were obtained with monocytes from
the same patients. As reported by other investigators, hemodial-
ysis with cellulosic membranes was associated with an increased
expression of CD11b on neutrophils and to a much lower extent
on monocytes. Levels of CD1 lb on neutrophils had increased by
five minutes of dialysis. Expression of CD11b at the end of the
dialysis procedure was significantly higher than that observed
prior to dialysis. No changes in CD11b expression on neutrophils
and monocytes occurred in patients dialyzed with polyacrylonitrile
membranes. Our results are in agreement with previous studies
[33—351 but conflicting with those reported by Tielmans et al [36].
However, it was suggested by the authors that dialysis with
polyacrylonitrile (AN69) could be associated with transfer of
bacterial products, a phenomenon which could not explain the
results of our study as particular attention was taken to prevent
the contamination with bacterial endotoxins. At the time of the
study no intracellular IL-i production (data not shown) was
observed in monocytes from patients dialyzed with high perme-
ability membranes, strongly indicating that the dialysate was
probably free of any endotoxin contamination [21, 37].
At the same time points in dialysis we simultaneously studied
CD15s and CD1 lb expression and the time course of neutrophil
and monocyte counts during hemodialysis with cuprophane and
polyacrylonitrile membranes. The results indicate that there was a
strong correlation between CD15s expression and the transient
margination of neutrophils and monocytes at all time points tested
(Fig. 3; P < 4 X iO for neutrophils; P < 6 X iO for monocytes
throughout the dialysis procedure), whereas the drop in monocyte
counts was independent on CD11b expression. Taken together,
these results indicate that the transient leukopenia induced in
patients dialyzed with cellulosic membranes is due to a mecha-
nism which involves selectin mediated events rather than to the
integrin adhesive phenomenon as suggested in earlier observa-
tions [38]. However, it can also be suggested that conformational
changes of CD11b could occur during hemodialysis [39], a phe-
nomenon which will not affect CD1 lb/CD 18 expression but will
involve their participation in margination. To investigate the
mechanisms involved in up-regulation of CD15s and CD11b on
neutrophils and monocytes, during the hemodialysis we cultured
blood cells in the presence of Sephadex-activated autologous
serum. We have previously shown that Sephadex activates human
complement and induces the generation of both C3a and C5a
anaphylatoxins in vitro [18]. We observed that CDl5s and CD11b
expression on neutrophils and monocytes incubated in comple-
ment-activated autologous serum is increased in a time dependent
fashion. However, if the cells were incubated in the presence of
recombinant C5a, the expression of CDl5s was not altered and
expression of CD1 lb was increased only on monocytes (Table 2).
This result does not totally rule out complement involvement
since anaphylatoxins could act in a permissive or synergistic
fashion with other mediators, or activation of the autologous
serum by Sephadex could also generate C3b and C3bi fragments
which may interact with CR1 (CD35) and CR3 (CDllb/CD18) on
both neutrophils and monocytes. However, it can be proposed
that incubation of Sephadex with serum may also generate
mediators which in turn may induce the release of platelet
activating factor (PAF). It is known that PAF and P-selectin act
synergistically in promoting the early adhesion of neutrophils to
endothelium [27, 38]; therefore, PAF may modulate CD15s
expression. This hypothesis is currently under investigation.
We have observed that both neutrophils and monocytes ex-
pressed CD62P antigens in patients dialyzed with cuprophane
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membranes but not on cells from patients dialyzed with poiy-
acrylonitrile membranes (AN69). Since CD62P antigens are ex-
pressed only on activated endothelial cells and activated platelets
[19, 40], we investigated CD62P expression on platelets during
hemodialysis. Platelets were gated in the logarithmic FSC versus
logarithmic SSC plots using the CD61 platelet-specific antibody.
The results indicate that platelets from patients dialyzed on
cuprophane membranes were maximally activated after 5 minutes
of dialysis whereas only a slight activation of platelets occurred in
patients dialyzed with polyacrylonitrile membranes. The latter
findings were also reported by other investigators using different
types of synthetic membranes [41, 42]. We also studied the
kinetics of platelet counts during hemodialysis. The data indicate
that there was no significant thrombocytopenia in patients hemo-
dialyzed with cuprophane membranes. At the same time points of
hemodialysis as those used to measure platelets counts and
CD62P expression we measured CD62P antigen on both neutro-
phils and monocytes. We observed that almost all monocytes (80
to 95%) expressed low levels of CD62P but only 30% of the
circulating neutrophils expressed this antigen. During hemoclial-
ysis, increased CD62P expression was detectable on monocytes
after just 5 minutes of dialysis and rose continuously to reach
maximal values at 15 minutes. In contrast the percentage of
CD62P neutrophils increased at 5 minutes, remained stable
throughout the procedure and remained elevated at the end of the
dialysis session as compared with predialysis values. The higher
affinity of monocytes for activated platelets as compared to
neutrophils cannot be attributed to a higher expression of CD15s
on monocytes, since monocytes expressed lower levels of CD15s
as compared to neutrophils prior to hemodialysis (MFI = 529
190 for neutrophils and 246 151 for monocytes). It should be
pointed out that neutrophils from hemodialyzed patients ex-
pressed lower levels of CD15s than cells from healthy individuals,
but monocytes from the patients expressed similar levels of CD15s
to normal monocytes (MFI = 529 190 vs. 666 164 for
neutrophils and 246 151 vs. 201 10 for monocytes). Despite
the absence of fall in platelet counts at the time when monocytes
and neutrophils expressed CD62P, we observed a small decrease
in CD15s expression on both type of cells (MFI = 529 190 vs.
462 148 for neutrophils and 246 151 vs. 188 135 for
monocytes) at 5 minutes into the session in all patients dialyzed
with cuprophane membranes. These results could be due to the
formation of platelet-leukocyte coaggregates which will not affect
platelet counts because the number of platelets in the circulation
is far higher than leukocytes numbers. When microscopic analysis
was performed on leukocytes isolated from patients dialyzed with
cuprophane membranes 15 minutes after the dialysis session, the
results indicated that formation of intact coaggregates between
platelets and leukocytes occurred (data not shown). Direct visu-
alization of platelet-neutrophil adhesion within the vascular lu-
men has been recently reported to occur in vivo in an animal
model [43]. The greater amounts of coaggregates formed with
monocytes as compared to neutrophils may be due to a different
conformation of the CD15s molecule on monocytes which allows
a better interaction with activated platelets or involvement of
another monocytic membrane molecule in the recognition of
activated platelets. In order to investigate the mechanism of
coaggregate formation we incubated whole blood cells from
several donors with Sephadex-activated autologous serum. The
results indicated that for both neutrophils and monocytes the
kinetics of CD62P expression were similar to those observed in
vivo. The percent of neutrophils expressing CD62P reached a
plateau at 5 minutes of incubation and the mean fluorescence
intensity of CD62P rose continously on monocytes. For both
neutrophils and monocytes, CD61 expression reached a maximal
value after 10 minutes of incubation in activated serum and
declined thereafter, indicating that platelets are either ingested or
detached from the cells. The apparent discrepancy between
CD62P and CD61 expression on both types of cells can be due to
the shedding of CD62P from activated platelets at the membrane
of cells or to an absorption of soluble CD62P. We and other
investigators [17] have found that soluble CD62P is present in the
serum of normal individuals. We have also observed that levels of
soluble CD62P increased in patients undergoing cardiopulmonary
bypass in which bioincompatibility of extracorporeal circulation is
closely related to hemodialysis [12]. We are currently investigating
the levels of soluble CD62P in hemodialyzed patients.
It has been demonstrated by in vitro studies that leukocytes
cultured in the presence of activated platelets induce superoxide
anion by monocytes and neutrophils through P-selectin/CD15s
interactions and that leukotrienes are generated during platelet-
neutrophil interactions [44, 45]. P-selectin also interacts in a
juxtacrine fashion with /32-integrins to increase phagocytosis by
neutrophils. It was also reported that neutrophils and platelets
may cooperate to increase the formation of PAF which is known
to be a potential mediator involved in the amplification of
inflammatory reactions. Taken together, our results indicate that
hemodialysis on cuprophane membranes is associated with an
increased expression of CD15s on neutrophils and monocytes.
Despite the fact that neutrophil margination has been attributed
to result from complement activation and generation of C3a and
C5a, our results indicate that modulation of CD15s is independent
of anaphylatoxin formation. We simultaneously observed in-
creased CD15s expression on leukocytes and a concomitant
coaggregate formation of platelets with neutrophils and mono-
cytes, the monocytes having a higher tendency to form coaggre-
gates. The P-selectin dependent coaggregation may contribute to
physiological effects resulting from hemodialysis with cuprophane
membranes since the leukocyte-platelet aggregates may impede
microcirculatory flow and may induce activation of leukocyte
function.
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